bioRxiv/medRxiv TRiP Review Activity

279 Reviews — eLife — Cancer Biology

Most recent first Previous |  Page 17: Articles 161-170  | Next

Intercellular Communication Compensates Intracellular Proliferative Signal Deficit during Liver Regeneration
Kaneko, K., Liang, Y., Liu, Q., Zhang, S., Song, D., Feng, G.-S.
10.1101/2022.05.16.492226 — Posted: 2023-02-08 — Discussion: 2023-08-29  eLife
Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen specific tumor cell killing by cytotoxic T cells
Mattes, A.-K., Puig Gamez, M., Martin, E., Boryn, L., Baskaran, P., Huber, H. J., Schuler, M., Park, J. E., Swee, L. K.
10.1101/2022.08.26.505456 — Posted: 2022-08-27 — Discussion: 2023-08-20  eLife
RAF autoinhibition and 14-3-3 proteins promote paradoxical activation
Mendiratta, G., McFall, T., Stites, E. C.
10.1101/849489 — Posted: 2019-11-20 — Discussion: 2023-07-19  eLife
ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer
Farmaki, E., Nath, A., Emond, R., Karimi, K. L., Grolmusz, V. K., Cosgrove, P. A., Bild, A. H.
10.1101/2022.12.27.522019 — Posted: 2022-12-27 — Discussion: 2023-07-19  eLife
Isoform-specific Disruption of the TP73 Gene Reveals a Critical Role for TAp73gamma in Tumorigenesis via Leptin
Kong, X., Yan, W., Sun, W., Zhang, Y., Yang, H. J., Chen, M., Chen, H., de Vere White, R. W., Zhang, J., Chen, X.
10.1101/2022.08.07.503085 — Posted: 2022-08-07 — Discussion: 2023-07-16  eLife
Treatment with Tumor-Treating Fields (TTFields) Suppresses Intercellular Tunneling Nanotube Formation In Vitro and Upregulates Immuno-Oncologic Biomarkers In Vivo in Malignant Mesothelioma
Sarkari, A., Korenfeld, S., Ladner, K., Wong, P., Padmanabhan, S., Vogel, R. I., Sherer, L., Courtemanche, N., Steer, C., Wainer-Satsir, K., Lou, E.
10.1101/2022.12.29.522223 — Posted: 2022-12-30 — Discussion: 2023-07-09  eLife
Vitamin D induces SIRT1 activation through K610 deacetylation in colon cancer
Garcia-Martinez, J. M., Chocarro-Calvo, A., Martinez-Useros, J., Fernandez-Acenero, M. J., Fiuza, M. C., Caceres-Rentero, J., De la Vieja, A., Barbachano, A., Munoz, A., Larriba, M. J., Garcia Jimenez, C.
10.1101/2023.02.22.529558 — Posted: 2023-02-24 — Discussion: 2023-07-06  eLife
Mutant SF3B1 promotes PDAC malignancy through TGF-β resistance
Simmler, P., Mengis, T., Van-Lehmann, K., Khales, A., Thomas, T., Rätsch, G., Stoffel, M., Schwank, G.
10.1101/2022.06.16.496393 — Posted: 2022-06-19 — Discussion: 2023-07-04  eLife
Fra1 is required for TGFβ1 induced collective invasion
Camacho, S., Nasir, A., Rahhal, R., Dominguez, M., Pearson, G. W.
10.1101/2020.11.14.383232 — Posted: 2020-11-15 — Discussion: 2023-06-29  eLife
Rewiring of master transcription factor cistromes during high-grade serous ovarian cancer development
Nameki, R., Chang, H., Yu, P. H., Abbasi, F., Lin, X., Reddy, J., Haro, M., Fonseca, M., Freedman, M. L., Drapkin, R., Corona, R., Lawrenson, K.
10.1101/2023.04.11.536378 — Posted: 2023-04-12 — Discussion: 2023-06-21  eLife

Evaluation Sources